1
|
Munck Af Rosenschold P, Zelefsky MJ, Apte AP, Jackson A, Oh JH, Shulman E, Desai N, Hunt M, Ghadjar P, Yorke E, Deasy JO. Image-guided radiotherapy reduces the risk of under-dosing high-risk prostate cancer extra-capsular disease and improves biochemical control. Radiat Oncol 2018; 13:64. [PMID: 29650035 PMCID: PMC5898030 DOI: 10.1186/s13014-018-0978-1] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2017] [Accepted: 02/15/2018] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND To determine if reduced dose delivery uncertainty is associated with daily image-guidance (IG) and Prostate Specific Antigen Relapse Free Survival (PRFS) in intensity-modulated radiotherapy (IMRT) of high-risk prostate cancer (PCa). METHODS Planning data for consecutive PCa patients treated with IMRT (n = 67) and IG-IMRT (n = 35) was retrieved. Using computer simulations of setup errors, we estimated the patient-specific uncertainty in accumulated treatment dose distributions for the prostate and for posterolateral aspects of the gland that are at highest risk for extra-capsular disease. Multivariate Cox regression for PRFS considering Gleason score, T-stage, pre-treatment PSA, number of elevated clinical risk factors (T2c+, GS7+ and PSA10+), nomogram-predicted risk of extra-capsular disease (ECD), and dose metrics was performed. RESULTS For IMRT vs. IG-IMRT, plan dosimetry values were similar, but simulations revealed uncertainty in delivered dose external to the prostate was significantly different, due to positioning uncertainties. A patient-specific interaction term of the risk of ECD and risk of low dose to the ECD (p = 0.005), and the number of elevated clinical risk factors (p = 0.008), correlate with reduced PRFS. CONCLUSIONS Improvements in PSA outcomes for high-risk PCa using IG-IMRT vs. IMRT without IG may be due to improved dosimetry for ECD.
Collapse
Affiliation(s)
- Per Munck Af Rosenschold
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA.,Department of Radiation Oncology, Rigshospitalet, Copenhagen, Denmark
| | - Michael J Zelefsky
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 22, New York, NY, 10065, USA.
| | - Aditya P Apte
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
| | - Andrew Jackson
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
| | - Jung Hun Oh
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
| | - Elliot Shulman
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 22, New York, NY, 10065, USA
| | - Neil Desai
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 22, New York, NY, 10065, USA.,Department of Radiation Oncology, University of Texas Southwestern, Dallas, TX, USA
| | - Margie Hunt
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
| | - Pirus Ghadjar
- Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 22, New York, NY, 10065, USA
| | - Ellen Yorke
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
| | - Joseph O Deasy
- Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, USA
| |
Collapse
|
2
|
Sumida I, Yamaguchi H, Kizaki H, Aboshi K, Tsujii M, Yoshikawa N, Yamada Y, Suzuki O, Seo Y, Isohashi F, Yoshioka Y, Ogawa K. Novel Radiobiological Gamma Index for Evaluation of 3-Dimensional Predicted Dose Distribution. Int J Radiat Oncol Biol Phys 2015; 92:779-86. [DOI: 10.1016/j.ijrobp.2015.02.041] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2014] [Revised: 01/31/2015] [Accepted: 02/23/2015] [Indexed: 10/23/2022]
|
3
|
Carl J, Sander L. Five-year follow-up using a prostate stent as fiducial in image-guided radiotherapy of prostate cancer. Acta Oncol 2015; 54:862-7. [PMID: 25539443 DOI: 10.3109/0284186x.2014.987355] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
PURPOSE To report results from the five-year follow-up on a previously reported study using image-guided radiotherapy (IGRT) of localized or locally advanced prostate cancer (PC) and a removable prostate stent as fiducial. MATERIAL AND METHODS Patients with local or locally advanced PC were treated using five-field 3D conformal radiotherapy (3DRT). The clinical target volumes (CTV) were treated to 78 Gy in 39 fractions using daily on-line image guidance (IG). Late genito-urinary (GU) and gastro-intestinal (GI) toxicities were scored using the radiotherapy oncology group (RTOG) score and the common toxicity score of adverse events (CTC) score. Urinary symptoms were also scored using the international prostate symptom score (IPSS). RESULTS Median observation time was 5.4 year. Sixty-two of the 90 patients from the original study cohort were eligible for toxicity assessment. Overall survival, cancer-specific survival and biochemical freedom from failure were 85%, 96% and 80%, respectively at five years after radiotherapy. Late toxicity GU and GI RTOG scores≥2 were 5% and 0%. Comparing pre- and post-radiotherapy IPSS scores indicate that development in urinary symptoms after radiotherapy may be complex. CONCLUSIONS Prostate image-guided radiotherapy using a prostate stent demonstrated survival data comparable with recently published data. GU and GI toxicities at five-year follow-up were low and comparable to the lowest toxicity rates reported. These findings support that the precision of the prostate stent technique is at least as good as other techniques. IPSS revealed a complex development in urinary symptoms after radiotherapy.
Collapse
Affiliation(s)
- Jesper Carl
- Department of Medical Physics, Oncology, Aalborg University Hospital , Aalborg , Denmark
| | | |
Collapse
|
4
|
Impact of magnetic resonance imaging on computed tomography-based treatment planning and acute toxicity for prostate cancer patients treated with intensity modulated radiation therapy. Pract Radiat Oncol 2013; 3:e1-e9. [DOI: 10.1016/j.prro.2012.04.005] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2012] [Revised: 04/10/2012] [Accepted: 04/13/2012] [Indexed: 11/19/2022]
|
5
|
Park JY, Lee JW, Chung JB, Choi KS, Kim YL, Park BM, Kim Y, Kim J, Choi J, Kim JS, Hong S, Suh TS. Radiobiological model-based bio-anatomical quality assurance in intensity-modulated radiation therapy for prostate cancer. JOURNAL OF RADIATION RESEARCH 2012; 53:978-988. [PMID: 22915778 PMCID: PMC3483850 DOI: 10.1093/jrr/rrs049] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 02/18/2012] [Revised: 06/11/2012] [Accepted: 06/12/2012] [Indexed: 06/01/2023]
Abstract
A bio-anatomical quality assurance (QA) method employing tumor control probability (TCP) and normal tissue complication probability (NTCP) is described that can integrate radiobiological effects into intensity-modulated radiation therapy (IMRT). We evaluated the variations in the radiobiological effects caused by random errors (r-errors) and systematic errors (s-errors) by evaluating TCP and NTCP in two groups: patients with an intact prostate (G(intact)) and those who have undergone prostatectomy (G(tectomy)). The r-errors were generated using an isocenter shift of ±1 mm to simulate a misaligned patient set-up. The s-errors were generated using individual leaves that were displaced inwardly and outwardly by 1 mm on multileaf collimator field files. Subvolume-based TCP and NTCP were visualized on computed tomography (CT) images to determine the radiobiological effects on the principal structures. The bio-anatomical QA using the TCP and NTCP maps differentiated the critical radiobiological effects on specific volumes, particularly at the anterior rectal walls and planning target volumes. The s-errors showed a TCP variation of -40-25% in G(tectomy) and -30-10% in G(intact), while the r-errors were less than 1.5% in both groups. The r-errors for the rectum and bladder showed higher NTCP variations at ±20% and ±10%, respectively, and the s-errors were greater than ±65% for both. This bio-anatomical method, as a patient-specific IMRT QA, can provide distinct indications of clinically significant radiobiological effects beyond the minimization of probable physical dose errors in phantoms.
Collapse
Affiliation(s)
- Ji-Yeon Park
- Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
- Research Institute of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
| | - Jeong-Woo Lee
- Research Institute of Health Science, College of Health Science, Korea University, Seoul 136-703, Korea
- Department of Radiation Oncology, Konkuk University Medical Center, Seoul 143-729, Korea
| | - Jin-Beom Chung
- Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea
| | - Kyoung-Sik Choi
- Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
- Research Institute of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
- Department of Radiation Oncology, Anyang SAM Hospital, Anyang 430-733, Korea
| | - Yon-Lae Kim
- Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
- Research Institute of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
- Department of Radiology, Choonhae College of Health Science, Ulsan 689-784, Korea
| | - Byung-Moon Park
- Department of Radiation Oncology, Konkuk University Medical Center, Seoul 143-729, Korea
| | - Youhyun Kim
- Department of Radiologic Science, College of Health Science, Korea University, Seoul 136-703, Korea
| | - Jungmin Kim
- Department of Radiologic Science, College of Health Science, Korea University, Seoul 136-703, Korea
| | - Jonghak Choi
- Department of Radiologic Science, College of Health Science, Korea University, Seoul 136-703, Korea
| | - Jae-Sung Kim
- Department of Radiation Oncology, Seoul National University Bundang Hospital, Seongnam 463-707, Korea
| | - Semie Hong
- Department of Radiation Oncology, Konkuk University Medical Center, Seoul 143-729, Korea
| | - Tae-Suk Suh
- Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
- Research Institute of Biomedical Engineering, The Catholic University of Korea, Seoul 137-701, Korea
| |
Collapse
|
6
|
Zhang M, Westerly DC, Mackie TR. Introducing an on-line adaptive procedure for prostate image guided intensity modulate proton therapy. Phys Med Biol 2011; 56:4947-65. [PMID: 21772078 DOI: 10.1088/0031-9155/56/15/019] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
With on-line image guidance (IG), prostate shifts relative to the bony anatomy can be corrected by realigning the patient with respect to the treatment fields. In image guided intensity modulated proton therapy (IG-IMPT), because the proton range is more sensitive to the material it travels through, the realignment may introduce large dose variations. This effect is studied in this work and an on-line adaptive procedure is proposed to restore the planned dose to the target. A 2D anthropomorphic phantom was constructed from a real prostate patient's CT image. Two-field laterally opposing spot 3D-modulation and 24-field full arc distal edge tracking (DET) plans were generated with a prescription of 70 Gy to the planning target volume. For the simulated delivery, we considered two types of procedures: the non-adaptive procedure and the on-line adaptive procedure. In the non-adaptive procedure, only patient realignment to match the prostate location in the planning CT was performed. In the on-line adaptive procedure, on top of the patient realignment, the kinetic energy for each individual proton pencil beam was re-determined from the on-line CT image acquired after the realignment and subsequently used for delivery. Dose distributions were re-calculated for individual fractions for different plans and different delivery procedures. The results show, without adaptive, that both the 3D-modulation and the DET plans experienced delivered dose degradation by having large cold or hot spots in the prostate. The DET plan had worse dose degradation than the 3D-modulation plan. The adaptive procedure effectively restored the planned dose distribution in the DET plan, with delivered prostate D(98%), D(50%) and D(2%) values less than 1% from the prescription. In the 3D-modulation plan, in certain cases the adaptive procedure was not effective to reduce the delivered dose degradation and yield similar results as the non-adaptive procedure. In conclusion, based on this 2D phantom study, by updating the proton pencil beam energy from the on-line image after realignment, this on-line adaptive procedure is necessary and effective for the DET-based IG-IMPT. Without dose re-calculation and re-optimization, it could be easily incorporated into the clinical workflow.
Collapse
Affiliation(s)
- M Zhang
- Department of Medical Physics, University of Wisconsin, Madison, WI 53705, USA.
| | | | | |
Collapse
|
7
|
Carl J, Nielsen J, Holmberg M, Larsen EH, Fabrin K, Fisker RV. Clinical results from first use of prostate stent as fiducial for radiotherapy of prostate cancer. Acta Oncol 2011; 50:547-54. [PMID: 21174520 DOI: 10.3109/0284186x.2010.541935] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
PURPOSE A clinical feasibility study using a removable prostate stent as fiducial for image-guided radiotherapy (IGRT) of localized prostate cancer (PC). MATERIAL AND METHODS The study included patients with local or locally advanced PC. The clinical target volume (CTV) was outlined on magnetic resonance (MR) images co-registered to planning computer tomography (CT) images. Daily online IGRT was delivered using the stent as fiducial. Risk of migration was estimated using multiple MR. Acute urinary toxicity was scored using the international prostate symptom score (IPSS). Late gastro-intestinal (GI) and genito-urinary (GU) toxicity was scored using the Radio Therapy Oncology Group (RTOG) score, biochemical failure (BF) was defined as an elevation of prostate specific antigen (PSA) above nadir plus 2 ng/ml after radiotherapy. RESULTS One hundred men were enrolled in the study. Ninety completed radiotherapy with the stent as fiducial. No migration of the stent was seen, but three cases of dislocation of the stent to the bladder were observed. Acute urinary toxicity based on IPSS was comparable to toxicity in patients who had gold markers (GM) as fiducials. Removal of the stent was associated with a high frequency of urinary retention. Late GI and GU toxicity and BF were comparable to those of other studies, but longer observation time is needed. CONCLUSIONS This study reports the first clinical results of using a prostate stent as fiducial. No migration of the stent observed. Dislocation of the stent to the urinary bladder was observed in three cases, requiring removal of the stent and insertion of a new fiducial. Acute toxicity during radiotherapy evaluated from IPSS was comparable to toxicity in patients with GM. Removal of the stent was associated with a high frequency of post procedural urinary retention. Late toxicity and BF were comparable to those of other studies, though longer observation time is needed.
Collapse
Affiliation(s)
- Jesper Carl
- Department of Medical Physics, Department of Oncology, Aalborg Hospital, Aarhus University Hospital, Aalborg, Denmark.
| | | | | | | | | | | |
Collapse
|
8
|
Shaffer R, Pickles T, Lee R, Moiseenko V. Deriving Prostate Alpha-Beta Ratio Using Carefully Matched Groups, Long Follow-Up and the Phoenix Definition of Biochemical Failure. Int J Radiat Oncol Biol Phys 2011; 79:1029-36. [DOI: 10.1016/j.ijrobp.2009.12.058] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/29/2009] [Revised: 12/14/2009] [Accepted: 12/14/2009] [Indexed: 12/01/2022]
|
9
|
Perks J, Turnbull H, Liu T, Purdy J, Valicenti R. Vector Analysis of Prostate Patient Setup With Image-Guided Radiation Therapy via kV Cone Beam Computed Tomography. Int J Radiat Oncol Biol Phys 2011; 79:915-9. [DOI: 10.1016/j.ijrobp.2010.04.008] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/07/2009] [Revised: 02/23/2010] [Accepted: 04/06/2010] [Indexed: 10/24/2022]
|
10
|
Fox C, Fisher R, Kron T, Tai KH, Thompson A, Owen R, Foroudi F. Extraction of data for margin calculations in prostate radiotherapy from a commercial record and verify system. J Med Imaging Radiat Oncol 2010; 54:161-70. [PMID: 20518881 DOI: 10.1111/j.1754-9485.2010.02156.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- C Fox
- Physical Sciences Department, Peter MacCallum Cancer Centre, East Melbourne, Australia.
| | | | | | | | | | | | | |
Collapse
|
11
|
Søndergaard J, Olsen KØ, Muren LP, Elstrøm UV, Grau C, Høyer M. A study of image-guided radiotherapy of bladder cancer based on lipiodol injection in the bladder wall. Acta Oncol 2010; 49:1109-15. [PMID: 20429726 DOI: 10.3109/02841861003789491] [Citation(s) in RCA: 40] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
PURPOSE We have tested a procedure of focal injection of the contrast medium Lipiodol as a fiducial marker for image-guided boost of the tumor in bladder cancer radiotherapy (RT). In this study, we have evaluated the feasibility and the safety of the method as well as the inter- and intra-fraction shift of the bladder tumor. MATERIALS AND METHODS Five patients with muscle invasive urinary bladder cancer were included in the study. Lipiodol was injected during flexible cystoscopy into the submucosa of the bladder wall at the periphery of the tumor or the post resection tumor-bed. Cone-beam CT (CBCT) scans were acquired daily throughout the course of RT. RESULTS Lipiodol demarcation of the bladder tumor was feasible and safe with only a minimum of side effects related to the procedure. The Lipiodol spots were visible on CT and CBCT scans for the duration of the RT course. More than half of all the treatment fractions required a geometric shift of 5 mm or more to match on the Lipiodol spots. The mean intra-fraction shift (3D) of the tumor was 3 mm, largest in the anterior-posterior and cranial-caudal directions. CONCLUSION This study demonstrates that Lipiodol can be injected into the bladder mucosa and subsequently visualized on CT and CBCT as a fiducial marker. The relatively large inter-fraction shifts in the positions of Lipiodol spots compared to the intra-fraction movement indicates that image-guided RT based on radio-opaque markers is important for RT of the bladder cancer tumor.
Collapse
Affiliation(s)
- Jimmi Søndergaard
- Department of Oncology, Aarhus University Hospital, Aarhus, Denmark.
| | | | | | | | | | | |
Collapse
|
12
|
Mzenda B, Hosseini-Ashrafi M, Palmer A, Liu H, Brown DJ. A simulation technique for computation of the dosimetric effects of setup, organ motion and delineation uncertainties in radiotherapy. Med Biol Eng Comput 2010; 48:661-9. [DOI: 10.1007/s11517-010-0616-z] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2009] [Accepted: 04/12/2010] [Indexed: 10/19/2022]
|
13
|
Varadhan R, Hui SK, Way S, Nisi K. Assessing prostate, bladder and rectal doses during image guided radiation therapy--need for plan adaptation? J Appl Clin Med Phys 2009; 10:56-74. [PMID: 19692971 PMCID: PMC5720560 DOI: 10.1120/jacmp.v10i3.2883] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2008] [Revised: 04/30/2009] [Accepted: 04/27/2009] [Indexed: 11/23/2022] Open
Abstract
The primary application of Image‐Guided Radiotherapy (IGRT) in the treatment of localized prostate cancer has been to assist precise dose delivery to the tumor. With the ability to use in‐room Computed Tomography (CT) imaging modalities, the prostate, bladder and rectum can be imaged before each treatment and the actual doses delivered to these organs can be tracked using anatomy of the day. This study evaluates the dosimetric uncertainties caused by interfraction organ variation during IGRT for 10 patients using kilovoltage cone beam CT (kvCBCT) on the Elekta Synergy system and megavoltage CT (MVCT) on the TomoTherapy Hi·Art System. The actual delivered doses to the prostate, bladder and rectum were based on dose recomputation using CT anatomy of the day. The feasibility of dose calculation accuracy in kvCBCT images from the Elekta Synergy system was investigated using the ComTom phantom. Additionally, low contrast resolution, image uniformity, and spatial resolution between the three imaging modalities of kilovoltage CT (kvCT), kvCBCT and MVCT images, were quantitatively evaluated using the Catphan 600 phantom. The Planned Adaptive software was used on the TomoTherapy Hi·Art system to construct a cumulative Dose Volume Histogram (DVH), incorporating anatomical information provided by the daily MVCT scans. The cumulative DVH was examined to identify large deviation (10% or greater) between the planned and delivered mean doses. The study proposes a framework that applies the cumulative DVH to evaluate and adapt plans that are based on actual delivered doses. Due to the large deviation in CT number (›300 HU) between the kvCBCT images and the kvCT, a direct dose recomputation on the kvCBCT images from the Elekta Synergy system was found to be inaccurate. The maximum deviation to the prostate was only 2.7% in our kvCBCT study, when compared to the daily prescribed dose. However, there was a large daily variation in rectum and bladder doses based on the anatomy of the day. The maximum variation in rectum and bladder volumes receiving the percentage of prescribed dose was 12% and 40%, respectively. We have shown that by using Planned Adaptive software on the TomoTherapy Hi·Art system, plans can be adapted based on the image feedback from daily MVCT scans to allow the actual delivered doses to closely track the original planned doses. PACS number: 87.53.Tf
Collapse
Affiliation(s)
- Raj Varadhan
- Minneapolis Radiation Oncology, North Radiation Therapy Center, Robbinsdale, MN, U.S.A.,Department of Therapeutic Radiology, University of Minnesota, Minneapolis, MN, U.S.A
| | - Susanta K Hui
- Department of Therapeutic Radiology, University of Minnesota, Minneapolis, MN, U.S.A
| | - Sarah Way
- Minneapolis Radiation Oncology, North Radiation Therapy Center, Robbinsdale, MN, U.S.A
| | - Kurt Nisi
- Minneapolis Radiation Oncology, North Radiation Therapy Center, Robbinsdale, MN, U.S.A
| |
Collapse
|
14
|
Gauthier I, Carrier JF, Béliveau-Nadeau D, Fortin B, Taussky D. Dosimetric Impact and Theoretical Clinical Benefits of Fiducial Markers for Dose Escalated Prostate Cancer Radiation Treatment. Int J Radiat Oncol Biol Phys 2009; 74:1128-33. [DOI: 10.1016/j.ijrobp.2008.09.043] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2008] [Revised: 09/01/2008] [Accepted: 09/06/2008] [Indexed: 11/16/2022]
|
15
|
Higgins J, Bezjak A, Franks K, Le LW, Cho B, Payne D, Bissonnette JP. Comparison of Spine, Carina, and Tumor as Registration Landmarks for Volumetric Image-Guided Lung Radiotherapy. Int J Radiat Oncol Biol Phys 2009; 73:1404-13. [DOI: 10.1016/j.ijrobp.2008.06.1926] [Citation(s) in RCA: 46] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/08/2008] [Revised: 06/27/2008] [Accepted: 06/29/2008] [Indexed: 11/30/2022]
|
16
|
Wong JR, Gao Z, Uematsu M, Merrick S, Machernis NP, Chen T, Cheng CW. Interfractional Prostate Shifts: Review of 1870 Computed Tomography (CT) Scans Obtained During Image-Guided Radiotherapy Using CT-on-Rails for the Treatment of Prostate Cancer. Int J Radiat Oncol Biol Phys 2008; 72:1396-401. [DOI: 10.1016/j.ijrobp.2008.03.045] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/20/2007] [Revised: 02/21/2008] [Accepted: 03/06/2008] [Indexed: 10/21/2022]
|
17
|
Carl J, Nielsen J, Holmberg M, Højkjær Larsen E, Fabrin K, Fisker RV. A new fiducial marker for Image-guided radiotherapy of prostate cancer: clinical experience. Acta Oncol 2008; 47:1358-66. [PMID: 18618341 DOI: 10.1080/02841860802241972] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
BACKGROUND A new fiducial marker for image guided radiotherapy (IGRT) based on a removable prostate stent made of Ni Ti has been developed during two previous clinical feasibility studies. The marker is currently being evaluated for IGRT treatment in a third clinical study. METHOD The new marker is used to co-register MR and planning CT scans with high accuracy in the region around the prostate. The co-registered MR-CT volumes are used for delineation of GTV before planning. In each treatment session the IGRT system is used to position the patient before treatment. The IGRT system use a stereo pair of kV images matched to corresponding Digital Reconstructed Radiograms (DRR) from the planning CT scan. The match is done using mutual gray scale information. The pair of DRR's for positioning is created in the IGRT system with a threshold in the Look Up Table (LUT). The resulting match provides the necessary shift in couch coordinates to position the stent with an accuracy of 1-2 mm within the planned position. RESULTS At the present time 39 patients have received the new marker. Of the 39 one has migrated to the bladder. Deviations of more than 5 mm between CTV outlined on CT and MR are seen in several cases and in anterior-posterior (AP), left-right (LR) and cranial-caudal (CC) directions. Intra-fraction translation movements up to +/- 3 mm are seen as well. As the stent is also clearly visible on images taken with high voltage x-rays using electronic portal images devices (EPID), the positioning has been verified independently of the IGRT system. DISCUSSION The preliminary result of an on going clinical study of a Ni Ti prostate stent, potentially a new fiducial marker for image guided radiotherapy, looks promising. The risk of migration appears to be much lower compared to previous designs.
Collapse
|
18
|
Cranmer-Sargison G. A Treatment Planning Investigation Into the Dosimetric Effects of Systematic Prostate Patient Rotational Set-Up Errors. Med Dosim 2008; 33:199-205. [DOI: 10.1016/j.meddos.2007.06.005] [Citation(s) in RCA: 15] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2007] [Revised: 06/21/2007] [Accepted: 06/22/2007] [Indexed: 12/01/2022]
|
19
|
Huang SH, Catton C, Jezioranski J, Bayley A, Rose S, Rosewall T. The Effect of Changing Technique, Dose, and PTV Margin on Therapeutic Ratio During Prostate Radiotherapy. Int J Radiat Oncol Biol Phys 2008; 71:1057-64. [DOI: 10.1016/j.ijrobp.2007.11.055] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2007] [Revised: 08/28/2007] [Accepted: 11/14/2007] [Indexed: 02/07/2023]
|
20
|
Alonso-Arrizabalaga S, Brualla González L, Roselló Ferrando JV, Pastor Peidro J, López Torrecilla J, Planes Meseguer D, García Hernández T. Prostate Planning Treatment Volume Margin Calculation Based on the ExacTrac X-Ray 6D Image-Guided System: Margins for Various Clinical Implementations. Int J Radiat Oncol Biol Phys 2007; 69:936-43. [PMID: 17889275 DOI: 10.1016/j.ijrobp.2007.06.063] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2007] [Revised: 06/07/2007] [Accepted: 06/22/2007] [Indexed: 10/22/2022]
Abstract
PURPOSE To assess the prostate motion from day-to-day setup, as well as during irradiation time, to calculate planning target volume (PTV) margins. PTV margins differ depending on the clinical implementation of an image-guided system. Three cases were considered in this study: daily bony anatomy match, center of gravity of the implanted marker seeds calculated with a limited number of imaged days, and daily online correction based on implanted marker seeds. METHODS AND MATERIALS A cohort of 30 nonrandomized patients and 1,330 pairs of stereoscopic kV images have been used to determine the prostate movement. The commercial image guided positioning tool employed was ExacTrac X-Ray 6D (BrainLAB AG, Feldkirchen, Germany). RESULTS Planning target volume margins such that a minimum of 95% of the prescribed dose covers the clinical target volume for 90% of the population are presented. PTV margins based on daily bony anatomy match, including intrafraction correction, would be 11.5, 13.5, and 4.5 mm in the anterior-posterior, superior-inferior, and right-left directions, respectively. This margin can be further reduced to 8.1, 8.6, and 4.8 mm (including intrafraction motion) if implanted marker seeds are used. Finally, daily on line correction based on marker seeds would result in the smallest of the studied margins: 4.7, 6.2, and 1.9 mm. CONCLUSION Planning target volume margins are dependent on the local clinical use of the image-guided RT system available in any radiotherapy department.
Collapse
Affiliation(s)
- Sara Alonso-Arrizabalaga
- Radiotherapy Physics, Exploraciones Radiológicas Especiales (ERESA), Hospital General Universitario, Valencia, Spain.
| | | | | | | | | | | | | |
Collapse
|
21
|
Gao Z, Wilkins D, Eapen L, Morash C, Wassef Y, Gerig L. A study of prostate delineation referenced against a gold standard created from the visible human data. Radiother Oncol 2007; 85:239-46. [PMID: 17825447 DOI: 10.1016/j.radonc.2007.08.001] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/18/2007] [Revised: 07/16/2007] [Accepted: 08/07/2007] [Indexed: 11/29/2022]
Abstract
PURPOSE To measure inter- and intra-observer variation and systematic error in CT based prostate delineation, where individual delineations are referenced against a gold standard produced from photographic anatomical images from the Visible Human Project (VHP). MATERIALS AND METHODS The CT and anatomical images of the VHP male form the basic data set for this study. The gold standard was established based on 1mm thick anatomical photographic images. These were registered against the 3mm thick CT images that were used for target delineation. A total of 120 organ delineations were performed by six radiation oncologists. RESULTS The physician delineated prostate volume was on average 30% larger than the "true" prostate volume, but on average included only 84% of the gold standard volume. Our study found a systematic delineation error such that posterior portions of the prostate were always missed while anteriorly some normal tissue was always defined as target. CONCLUSIONS Our data suggest that radiation oncologists are more concerned with the unintentional inclusion of rectal tissue than they are in missing prostate volume. In contrast, they are likely to overextend the anterior boundary of the prostate to encompass normal tissue such as the bladder.
Collapse
Affiliation(s)
- Zhanrong Gao
- Department of Physics, Carleton University, Ottawa, Canada
| | | | | | | | | | | |
Collapse
|
22
|
Speight JL, Roach M. Advances in the Treatment of Localized Prostate Cancer: The Role of Anatomic and Functional Imaging in Men Managed With Radiotherapy. J Clin Oncol 2007; 25:987-95. [PMID: 17350948 DOI: 10.1200/jco.2006.10.3218] [Citation(s) in RCA: 23] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Radiation therapy is an active modality in the management of local and regional prostate cancer, but can be curative only if all existing disease is encompassed within the treatment portal. In addition to the ability to deliver sufficient radiation dose, accurate targeting is critical to achieve better treatment outcomes. Failure to accommodate daily variations in setup and organ motion potentially limits the efficacy of sophisticated conformal techniques (three-dimensional conformal radiotherapy and intensity-modulated radiotherapy). Increased use of various online and real-time imaging techniques is an important step toward enhancing treatment accuracy. The incorporation of functional imaging techniques into treatment planning is another important step. The addition of biologic and metabolic information regarding the location and extent of disease combined with real-time online imaging will allow us to better determine where, how, and with what to treat appropriate targets and improve cure rates.
Collapse
Affiliation(s)
- Joycelyn L Speight
- Department of Radiation Oncology, University of California San Francisco, Comprehensive Cancer Center, San Francisco, CA 94115-1708, USA.
| | | |
Collapse
|
23
|
Abstract
The relative doses and hot/cold spot positions around a non-radioactive gold seed, irradiated by a 6 or 18 MV photon beam in water, were calculated using Monte Carlo simulation. Phase space files of 6 and 18 MV photon beams with a field size of 1 x 1 cm2 were generated by a Varian 21 EX linear accelerator using the EGSnrc and BEAMnrc code. The seed (1.2 x 1.2 x 3.2 mm3) was positioned at the isocenter in a water phantom (20 x 20 x 20 cm2) with source-to-axis distance = 100 cm. For the single beam geometry, the relative doses (normalized to the dose at 5 mm distance above the isocenter) at the upstream seed surface were calculated to be 1.64 and 1.56 for the 6 and 18 MV beams respectively when the central beam axis (CAX) is parallel to the width of the seed. These doses were slightly higher than those (1.58 and 1.52 for 6 and 18 MV beams respectively) calculated when the CAX is perpendicular to the width of the seed. Compared to the relative dose profiles with the same beam geometry without the seed in the water phantom, the presence of the seed affects the dose distribution at about 3 mm distance beyond both the upstream and downstream seed surface. For a pair of opposing beams with equal and unequal beam weight, the hot and cold spots of both opposing beams were mixed. For a 360 degree photon arc around the longitudinal axis of the seed, the relative dose profile along the width of the seed was similar to that of the opposing beam pair, except the former geometry has a larger dose gradient near the seed surface. In this study, selected results from our simulation were compared to previous measurements using film dosimetry.
Collapse
Affiliation(s)
- James C L Chow
- Department of Radiation Oncology, University of Toronto and Radiation Medicine Program, Princess Margaret Hospital, 610 University Avenue, Toronto, ON N2G 1G3, Canada.
| | | |
Collapse
|
24
|
Fuller CD, Thomas CR, Schwartz S, Golden N, Ting J, Wong A, Erdogmus D, Scarbrough TJ. Method comparison of ultrasound and kilovoltage x-ray fiducial marker imaging for prostate radiotherapy targeting. Phys Med Biol 2006; 51:4981-93. [PMID: 16985282 DOI: 10.1088/0031-9155/51/19/016] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Several measurement techniques have been developed to address the capability for target volume reduction via target localization in image-guided radiotherapy; among these have been ultrasound (US) and fiducial marker (FM) software-assisted localization. In order to assess interchangeability between methods, US and FM localization were compared using established techniques for determination of agreement between measurement methods when a 'gold-standard' comparator does not exist, after performing both techniques daily on a sequential series of patients. At least 3 days prior to CT simulation, four gold seeds were placed within the prostate. FM software-assisted localization utilized the ExacTrac X-Ray 6D (BrainLab AG, Germany) kVp x-ray image acquisition system to determine prostate position; US prostate targeting was performed on each patient using the SonArray (Varian, Palo Alto, CA). Patients were aligned daily using laser alignment of skin marks. Directional shifts were then calculated by each respective system in the X, Y and Z dimensions before each daily treatment fraction, previous to any treatment or couch adjustment, as well as a composite vector of displacement. Directional shift agreement in each axis was compared using Altman-Bland limits of agreement, Lin's concordance coefficient with Partik's grading schema, and Deming orthogonal bias-weighted correlation methodology. 1,019 software-assisted shifts were suggested by US and FM in 39 patients. The 95% limits of agreement in X, Y and Z axes were +/-9.4 mm, +/-11.3 mm and +/-13.4, respectively. Three-dimensionally, measurements agreed within 13.4 mm in 95% of all paired measures. In all axes, concordance was graded as 'poor' or 'unacceptable'. Deming regression detected proportional bias in both directional axes and three-dimensional vectors. Our data suggest substantial differences between US and FM image-guided measures and subsequent suggested directional shifts. Analysis reveals that the vast majority of all individual US and FM directional measures may be expected to agree with each other within a range of 1-1.5 cm. Since neither system represents a gold standard, clinical judgment must dictate whether such a difference is of import. As IMRT protocols seek dose escalation and PTV reduction predicated on US- and FM-guided imaging, future studies are needed to address these potential clinically relevant issues regarding the interchangeability and accuracy of novel positional verification techniques. Comparison series with multiple image-guidance systems are needed to refine comparisons between targeting methods. However, we do not advocate interchangeability of US and FM localization methods.
Collapse
Affiliation(s)
- Clifton David Fuller
- Department of Radiation Oncology, University of Texas Health Science Center-San Antonio, USA
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Zhang M, Moiseenko V, Liu M. PTV margin for dose escalated radiation therapy of prostate cancer with daily on-line realignment using internal fiducial markers: Monte Carlo approach and dose population histogram (DPH) analysis. J Appl Clin Med Phys 2006; 7:38-49. [PMID: 17533327 PMCID: PMC5722437 DOI: 10.1120/jacmp.v7i2.2210] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2005] [Revised: 03/22/2006] [Accepted: 12/31/1969] [Indexed: 12/25/2022] Open
Abstract
Using internal fiducial markers and electronic portal imaging (EPI) to realign patients has been shown to significantly reduce positioning uncertainties in prostate radiation treatment. This creates the possibility of decreasing the planning target volume (PTV) margin added on the clinical target volume (CTV), which in turn may allow for dose escalation. We compared the outcome of two plans: 70 Gy/35 fx, 10‐mm PTV margin without patient realignment (Reference Plan) and 78 Gy/39 fx, 5‐mm PTV margin with patient realignment (Escalated Plan). Four‐field‐oblique (gantry angles 35°, 90°, 270°, 325°) beam arrangement was used. Monte Carlo code was used to simulate the daily organ motion. Dose to each organ was calculated. Tumor control probability (TCP) and the effective dose to critical organs (Deff) were calculated using the biologically normalized dose‐volume histograms. By comparing the biological factors, we found that the prescription dose can be escalated to 78 Gy/39 fx with a 5‐mm PTV margin when using internal fiducial markers and EPI. Based on the available dose‐response data for intermediate risk prostate patients, this will result in a 20% increase of local control and significantly reduced rectal complications provided that less serial dose‐volume behavior of rectum is proven. PACS number: 87.50.‐a
Collapse
Affiliation(s)
- Miao Zhang
- Department of Medical Physics, British Columbia Cancer Agency-Fraser Valley Centre, Surrey, British Columbia, Canada.
| | | | | |
Collapse
|
26
|
Moiseenko V, Liu M, Kristensen S, Gelowitz G, Berthelet E. Effect of bladder filling on doses to prostate and organs at risk: a treatment planning study. J Appl Clin Med Phys 2006; 8:55-68. [PMID: 17592448 PMCID: PMC5722405 DOI: 10.1120/jacmp.v8i1.2286] [Citation(s) in RCA: 36] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2006] [Revised: 12/14/2006] [Accepted: 12/31/1969] [Indexed: 12/25/2022] Open
Abstract
In the present study, we aimed to evaluate effects of bladder filling on dose–volume distributions for bladder, rectum, planning target volume (PTV), and prostate in radiation therapy of prostate cancer. Patients (n=21) were scanned with a full bladder, and after 1 hour, having been allowed to void, with an empty bladder. Radiotherapy plans were generated using a four‐field box technique and dose of 70 Gy in 35 fractions. First, plans obtained for full‐ and empty‐bladder scans were compared. Second, situations in which a patient was planned on full bladder but was treated on empty bladder, and vice versa, were simulated, assuming that patients were aligned to external tattoos. Doses to the prostate [equivalent uniform dose (EUD)], bladder and rectum [effective dose (Deff)], and normal tissue complication probability (NTCP) were compared. Dose to the small bowel was examined. Mean bladder volume was 354.3 cm3 when full and 118.2 cm3 when empty. Median prostate EUD was 70 Gy for plans based on full‐ and empty‐bladder scans alike. The median rectal Deff was 55.6 Gy for full‐bladder anatomy and 56.8 Gy for empty‐bladder anatomy, and the corresponding bladder Deff was 29.0 Gy and 49.3 Gy respectively. In 1 patient, part of the small bowel (7.5 cm3) received more than 50 Gy with full‐bladder anatomy, and in 6 patients, part (2.5 cm3−30 cm3) received more than 50 Gy with empty‐bladder anatomy. Bladder filling had no significant impact on prostate EUD or rectal Deff. A minimal volume of the small bowel received more than 50 Gy in both groups, which is below dose tolerance. The bladder Deff was higher with empty‐bladder anatomy; however, the predicted complication rates were clinically insignificant. When the multileaf collimator pattern was applied in reverse, substantial underdosing of the planning target volume (PTV) was observed, particularly for patients with prostate shifts in excess of 0.5 cm in any one direction. However, the prostate shifts showed no correlation with bladder filling, and therefore the PTV underdosing also cannot be related to bladder filling. For some patients, bladder dose–volume constraints were not fulfilled in the worst‐case scenario—that is, when a patient planned with full bladder consistently arrived for treatment with an empty bladder. PACS numbers: 87.53.‐j, 87.53.Kn, 87.53.Tf
Collapse
Affiliation(s)
- Vitali Moiseenko
- Fraser Valley Centre, British Columbia Cancer Agency, Surrey, British Columbia, Canada.
| | | | | | | | | |
Collapse
|